Results 111 to 120 of about 8,262 (195)

Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131- H 30Rx and ST131- H 30R1 Strains [PDF]

open access: yes, 2017
Escherichia coli sequence type 131 (ST131) predominates globally among multidrug-resistant (MDR) E. coli strains. We used whole-genome sequencing (WGS) to investigate 63 MDR E. coli isolates from 7 North Carolina community hospitals (2010 to 2015).
Kanamori, Hajime   +8 more
core   +1 more source

Determine the prevalence and fluoroquinolone resistance pattern of Escherichia coli ST131 among clinical isolates from vaginitis patients

open access: yesMedical Journal of Babylon
Background: The most interesting lineage of Escherichia coli is the sequence type 131 (ST131), a pandemic clone that is responsible for the high incidence of E.
Noor Ismeal Nasser   +2 more
doaj   +1 more source

Behavior of E. coli ST131 regarding the acquisition of a blaOXA-48 encoding plasmid [PDF]

open access: yes, 2021
Antimicrobial resistance has been a challenge ever since the discovery of antibiotics. The rising challenge of resistance has led to the increased use of last-resort antibiotics: carbapenems. It is predicted that a successful E.
Anfinsen, Oda-Mari
core  

Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131 [PDF]

open access: yes, 2016
UNLABELLED: Escherichia coli ST131 is the most frequently isolated fluoroquinolone-resistant (FQR) E. coli clone worldwide and a major cause of urinary tract and bloodstream infections.
Ben Zakour, NL   +7 more
core   +1 more source

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center

open access: yesmSphere, 2016
The H30 strain of Escherichia coli sequence type 131 (ST131-H30) is a recently emerged, globally disseminated lineage associated with fluoroquinolone resistance and, via its H30Rx subclone, the CTX-M-15 extended-spectrum beta-lactamase (ESBL).
James R. Johnson   +5 more
doaj   +1 more source

Escherichia coli ST131: Variations on a theme of clonal expansion [PDF]

open access: yesEnfermedades Infecciosas y Microbiología Clínica, 2013
Ritu, Banerjee, James R, Johnson
openaire   +2 more sources

The Role of AcrAB–TolC Efflux Pumps on Quinolone Resistance of E. coli ST131

open access: yesCurrent Microbiology, 2018
Escherichia coli ST131 is a cause for global concern because of its high multidrug resistance and several virulence factors. In this study, the contribution of acrAB-TolC efflux system of E. coli ST131 to fluoroquinolone resistance was evaluated. A total of nonrepetitive 111 ciprofloxacin-resistant E.
N, Atac   +6 more
openaire   +5 more sources

Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131

open access: yesPLoS ONE, 2012
The current spread of the gene encoding the metallo-ß-lactamase NDM-1 in Enterobacteriaceae is linked to a variety of surrounding genetic structures and plasmid scaffolds.The whole sequence of plasmid pGUE-NDM carrying the bla(NDM-1) gene was determined by high-density pyrosequencing and a genomic comparative analysis with other bla(NDM-1)-negative ...
Bonnin R. A   +3 more
openaire   +5 more sources

Microbiome features associated with persistent intestinal carriages of Escherichia coli ST131 in a Southeast Asian cohort study

open access: yesNature Communications
Escherichia coli sequence-type 131 (ST131) is the dominant global extraintestinal pathogen capable of asymptomatic intestinal carriage and sustained household transmission, challenging infection control.
Adrian Low   +14 more
doaj   +1 more source

A population phylogenomic analysis of the origin and spread of Escherichia coli sequence type 131 (ST131) [PDF]

open access: yes, 2019
The incidence of infections caused by extraintestinal Escherichia coli (ExPEC) is rising globally due to their increasing resistance to standard antibiotics.
Decano, Arun Gonzales
core   +1 more source

Home - About - Disclaimer - Privacy